# Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

> **NCT06295965** · — · RECRUITING · sponsor: **University of Washington** · enrollment: 2000 (estimated)

## Conditions studied

- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
- Recurrent Malignant Solid Neoplasm
- Clonal Cytopenia of Undetermined Significance
- Clonal Hematopoiesis
- Idiopathic Cytopenia of Undetermined Significance
- Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
- Ovarian Carcinoma
- Myeloid Neoplasm Post Cytotoxic Therapy

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT06295965
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2028-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06295965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06295965, "Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06295965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*